Literature DB >> 10544113

Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.

D L Lichtenstein1, J K Craigo, C Leroux, K E Rushlow, R F Cook, S J Cook, C J Issel, R C Montelaro.   

Abstract

The long terminal repeat (LTR) is reported to be one of the most variable portions of the equine infectious anemia virus (EIAV) genome. To date, however, no information is available on the effects of observed sequence variations on viral replication properties, despite a widespread assumption of the biological importance of EIAV LTR variation. EIAV LTR sequence variability is confined mostly to a small portion of the enhancer within the U3 segment of the LTR. Analysis of published EIAV LTR sequences revealed six different types of LTR based on the pattern of putative transcription factor motifs within the variable region of the enhancer. To test directly the significance of LTR variation, the in vitro and in vivo replication properties of two variant LTR species were investigated using two isogenic viruses, EIAV(19-2) and EIAV(19-2-6A), differing only within the enhancer region. The results of these studies demonstrated that the two variants replicated with similar kinetics and to equal levels in cultured equine fibroblasts or in equine macrophage, the natural target cell of EIAV, even after prolonged serial passage in the latter cell type. Furthermore, EIAV(19-2) and EIAV(19-2-6A) variants demonstrated similar replication levels in experimentally infected ponies. However, ponies infected with EIAV(19-2-6A) exhibited a rapid switch in the prevalent LTR type, such that by 112 days postinfection, no original-LTR-type viruses were evident. This specific and rapid shift in LTR quasispecies indicates an in vivo selection that is not reflected in simple in vitro replication rates, suggesting undefined selection pressures in vivo that drive LTR variation during persistent EIAV infection. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544113     DOI: 10.1006/viro.1999.9921

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13.

Authors:  Xu Qi; Xuefeng Wang; Shuai Wang; Yuezhi Lin; Chenggang Jiang; Jian Ma; Liping Zhao; Xiaoling Lv; Rongxian Shen; Fenglong Wang; Xiangang Kong; Zhiqiang Su; Jianhua Zhou
Journal:  Virus Genes       Date:  2010-06-05       Impact factor: 2.332

2.  Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.

Authors:  Wendy Maury; Robert J Thompson; Quentin Jones; Sarahann Bradley; Tara Denke; Prasith Baccam; Matthew Smazik; J Lindsay Oaks
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.

Authors:  Susan L Payne; Xiao-fang Pei; Bin Jia; Angela Fagerness; Frederick J Fuller
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

4.  Genetic variability and in vitro transcriptional permissibility of primary ovine beta-retrovirus promoter isolates.

Authors:  Christina D Eckstrand; Diego Castillo; Samantha J McDonnel; Chadwick N Hillman; Natasha Vapniarsky; Sundarvili Shanthalingam; Marcelo de las Heras; Brian G Murphy
Journal:  Am J Vet Res       Date:  2013-11       Impact factor: 1.156

5.  An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.

Authors:  Jodi K Craigo; Shannon Barnes; Baoshan Zhang; Sheila J Cook; Laryssa Howe; Charles J Issel; Ronald C Montelaro
Journal:  Retrovirology       Date:  2009-10-20       Impact factor: 4.602

Review 6.  Equine infectious anemia virus in China.

Authors:  Hua-Nan Wang; Dan Rao; Xian-Qiu Fu; Ming-Ming Hu; Jian-Guo Dong
Journal:  Oncotarget       Date:  2017-08-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.